search button
Open Access

[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo

  • Authors:
    • Chong Zhang
    • Shuang-Shuang Zhou
    • Xiang-Rong Li
    • Bao-Ming Wang
    • Neng-Ming Lin
    • Lin-Yi Feng
    • Da-Yong Zhang
    • Li-Huang Zhang
    • Jun-Bo Wang
    • Jian-Ping Pan

  • View Affiliations

  • Published online on: July 24, 2024     https://doi.org/10.3892/or.2024.8783
  • Article Number: 124

  • Copyright : © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

October-2024
Volume 52 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.8
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.5
  • CiteScore Rank: Q1: #74/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.719
  • SCImago Journal Rank (SJR): 0.864
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang C, Zhou S, Li X, Wang B, Lin N, Feng L, Zhang D, Zhang L, Wang J, Pan J, Pan J, et al: [Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 <em>in vitro</em> and <em>in vivo</em>. Oncol Rep 52: 124, 2024.
APA
Zhang, C., Zhou, S., Li, X., Wang, B., Lin, N., Feng, L. ... Pan, J. (2024). [Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 <em>in vitro</em> and <em>in vivo</em>. Oncology Reports, 52, 124. https://doi.org/10.3892/or.2024.8783
MLA
Zhang, C., Zhou, S., Li, X., Wang, B., Lin, N., Feng, L., Zhang, D., Zhang, L., Wang, J., Pan, J."[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 <em>in vitro</em> and <em>in vivo</em>". Oncology Reports 52.4 (2024): 124.
Chicago
Zhang, C., Zhou, S., Li, X., Wang, B., Lin, N., Feng, L., Zhang, D., Zhang, L., Wang, J., Pan, J."[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 <em>in vitro</em> and <em>in vivo</em>". Oncology Reports 52, no. 4 (2024): 124. https://doi.org/10.3892/or.2024.8783